1,721,671 research outputs found
Thalidomide therapy for myelodysplastic syndromes: current status and future perspectives
No full textHepatitis C virus infection and B-cell non-Hodgkin's lymphomas: more than a simple association
No full text
Thalidomide therapy in adult patients with myelodysplastic syndrome: a north central cancer treatment group phase II trial
No full textUsing rHuG-CSF in Multiple Myeloma: Consolidated Data, Evolutions, and New Concepts
No full textThe major risk of infection in cancer patients is correlated with duration and severity of chemotherapy-induced neutropenia, which depend on several factors, including the underlying disease, patient’s related characteristics, the intensity of chemotherapy, bone marrow reserve, the use of hematopoietic growth factors, and the stem cell dose in case of transplantation [1, 2]
Monoclonal Antibodies and Multiple Myeloma: All in All It's Just Another Brick in the Wall?
No full textThis commentary offers insight about the recent review by the European Medicines Agency on the approval of daratumumab for the treatment of adult patients with multiple myeloma.</jats:p
Hypomethylating agents for the treatment of acute myeloid leukemia in the elderly: for all, none, or which patients?
No full text- …
